Tibet Cheezheng Tibetan Medicine Co., Ltd. Stock

Equities

002287

CNE100000FM9

Pharmaceuticals

End-of-day quote Shenzhen S.E. 18:00:00 2024-06-19 EDT 5-day change 1st Jan Change
19.78 CNY -1.30% Intraday chart for Tibet Cheezheng Tibetan Medicine Co., Ltd. -2.94% -12.05%

Financials

Sales 2022 2.04B 282M 386M Sales 2023 2.05B 282M 386M Capitalization 11.92B 1.64B 2.25B
Net income 2022 472M 65.01M 89.06M Net income 2023 581M 80.02M 110M EV / Sales 2022 5.65 x
Net cash position 2022 505M 69.53M 95.25M Net cash position 2023 831M 114M 157M EV / Sales 2023 5.42 x
P/E ratio 2022
25.7 x
P/E ratio 2023
20.5 x
Employees 3,091
Yield 2022
1.71%
Yield 2023
2.13%
Free-Float 10.61%
More Fundamentals * Assessed data
Dynamic Chart
Tibet Cheezheng Tibetan Medicine Co., Ltd. Approves Cash Dividend for the Year 2023 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Approves the Election of Guo De'an as Independent Director CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tibet Cheezheng Tibetan Medicine's Profit Rises 29.5% in 2023; Shares Up 5% MT
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on July 20, 2023 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Approves Cash Dividend for the Year 2022 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tibet Cheezheng Tibetan Medicine Logs 34.1% Drop in 2022 Profit MT
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on 19 July 2022 CI
More news
1 day-1.30%
1 week-2.94%
Current month-8.34%
1 month-11.46%
3 months-11.22%
6 months-12.52%
Current year-12.05%
More quotes
1 week
19.70
Extreme 19.7
20.45
1 month
19.70
Extreme 19.7
22.37
Current year
16.27
Extreme 16.27
23.26
1 year
16.27
Extreme 16.27
26.48
3 years
16.27
Extreme 16.27
35.50
5 years
16.27
Extreme 16.27
45.23
10 years
14.90
Extreme 14.9037
50.30
More quotes
Managers TitleAgeSince
Director of Finance/CFO 54 18-08-28
President 60 09-01-23
Chairman 71 07-10-07
Members of the board TitleAgeSince
Chairman 71 07-10-07
Director/Board Member 62 22-07-12
Director/Board Member 48 20-12-20
More insiders
Date Price Change Volume
24-06-20 19.78 -1.30% 819,868
24-06-19 20.04 -0.94% 681,817
24-06-18 20.23 -0.20% 762,700
24-06-17 20.27 -0.30% 661,392
24-06-14 20.33 -0.25% 1,063,830

End-of-day quote Shenzhen S.E., June 19, 2024

More quotes
Tibet Cheezheng Tibetan Medicine Co., Ltd is a China-based company, principally engaged in the research, development, manufacture and distribution of Tibetan medicines. The Company primarily offers medicines under emplastrum, ointment, granule, crude drugs and others. The Company's products include external pain relieving series, including Cheezheng Xiaotong emplastrum, Qingpeng ointment and Baimai ointment, as well as oral medicine series. The Company distributes its products within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. 002287 Stock